GleamWall
中文EN

NATR NATURES SUNSHINE PRODUCTS INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 275053 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.2%
TTM net income YoY-2.9%
TTM EPS YoY1.2%
Revenue 3-yr CAGR3.0%
Net income 3-yr CAGR22.0%

Margins

Gross margin73.1%
Operating margin5.3%
Net margin3.1%
FCF margin2.2%
EBITDA margin8.1%

Returns

ROE8.8%
ROA5.5%
ROIC (approx.)21.5%
Asset turnover1.80x

Leverage & solvency

Liabilities / assets36.0%
Debt / equity0.00x
Current ratio2.56x
Interest coverage176.76x

Cash quality & payout

Operating cash flow / net income1.34x
Accruals ratio-1.9%
Payout ratio—
Capex / revenue1.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$480.14M$454.36M
Cost of revenue$132.42M$129.68M
Gross profit$347.72M$324.69M
R&D expense$1.90M$1.70M
SG&A expense$178.39M$164.00M
Operating income$24.74M$20.09M
Interest expense$98,000$146,000
Pretax income$29.81M$18.43M
Income tax$9.36M$10.53M
Net income$19.52M$7.70M
EBITDA$38.59M$34.31M
EPS (basic)1.080.41
EPS (diluted)1.060.40
Weighted avg. shares (diluted)18.47M19.09M
Balance sheet
Cash & equivalents$93.89M$84.70M
Receivables$8.60M$9.48M
Inventory$68.31M$59.44M
Current assets$178.84M$160.58M
PP&E, net$32.91M$39.59M
Total assets$261.15M$240.85M
Current liabilities$78.54M$65.69M
Total liabilities$99.59M$79.86M
Shareholders' equity$161.55M$155.31M
Shares outstanding17.51M18.48M
Cash flow statement
Operating cash flow$35.32M$25.30M
Capital expenditure$6.48M$10.97M
Free cash flow$28.84M$14.33M
Investing cash flow-$6.48M-$10.97M
Financing cash flow-$23.77M-$9.90M
Depreciation & amortization$13.84M$14.22M
Stock-based compensation$5.78M$4.79M
Share buybacks$16.31M$8.86M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.